ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
failure to respond or late response
on 02 Apr 2018
Last Applicant/ Owned by
Via Giacometti 1
Lugano
CH
6900
Serial Number
86758031 filed on 16th Sep 2015
Registration Number
N/A
Correspondent Address
Michael Culver
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
LACTOBACILLUS BREVIS DSM27961
Pharmaceuticals, namely, lactic acid bacteria for medical purposes; pharmaceutical preparations containing lactic acid bacteria for treating digestive diseases and conditions; food and dietary supplements containing lactic acid bacteria; lactic acid bacteria compositions for use as a drug for treating digestive diseases and conditions and as dietary/food supplement; all of the aforementioned goods Read More
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceuticals, namely, lactic acid bacteria for medical purposes; pharmaceutical preparations containing lactic acid bacteria for treating digestive diseases and conditions; food and dietary supplements containing lactic acid bacteria; lactic acid bacteria compositions for use as a drug for treating digestive diseases and conditions and as dietary/food supplement; all of the aforementioned goods featuring lactobacillus brevis
Mark Details
Serial Number
No 86758031
Mark Type
No Service/Collective Mark
Attorney Docket Number
No Mendes 18-T
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 02th Apr 2018 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| 02th Apr 2018 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
| 23rd Aug 2017 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| 23rd Aug 2017 | FINAL REFUSAL E-MAILED |
| 23rd Aug 2017 | FINAL REFUSAL WRITTEN |
| 04th Aug 2017 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 03rd Aug 2017 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 03rd Aug 2017 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 03rd Feb 2017 | NON-FINAL ACTION E-MAILED |
| 03rd Feb 2017 | NON-FINAL ACTION WRITTEN |